The glutamine market, valued at USD 130.94 million in 2023, is projected to reach USD 175.27 million by 2033, growing at a 3.2% CAGR. L-glutamine dominates with an 83% market share, while muscle-building applications lead with 36% in 2023. North America holds the largest market share at 40%, though other regions are expected to gain traction in the fitness trend.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5119
MuscleTech Platinum 100% Glutamine is a top-notch sports nutrition product made of pure L-glutamine powder. It’s been proven in studies to help muscles recover faster and decrease soreness after working out. This product is in high demand because athletes find it useful for their training needs.
The glutamine market has witnessed significant growth owing to its diverse applications and increasing awareness of its health benefits. Glutamine, an essential amino acid found abundantly in various foods, serves as a fundamental building block for proteins. It supports immune function by aiding in the body’s defense against infections and also plays a crucial role in maintaining digestive health, particularly in the integrity of the intestinal lining. Given its importance, glutamine has become a popular dietary supplement, with healthcare professionals and consumers recognizing its significance in promoting overall well-being.
In 2022, the American Cancer Society estimated that about 1.92 million people in the United States will get cancer, and around 609,360 will pass away from it. Globally, that adds up to 9.6 million lives lost to cancer. Because diseases like cancer are becoming more common, there’s a significant need for new and better treatments all around the world. One treatment that’s getting attention is using a substance called glutamine to help manage cancer. Glutamine is a type of amino acid that seems to help people going through cancer treatment stay healthier overall. Adding glutamine to cancer treatments is part of a more significant effort to make sure patients do better and feel better during their treatment. Since diseases like cancer keep causing big problems, it’s really important for doctors and scientists to keep looking for new and better ways to treat them.
Recent Newsletter
- In September 2023, Johns Hopkins Medicine shared exciting findings from early tests of a new type of medicine called a “prodrug” that targets glutamine in tumors. This drug explicitly attacks cancer cells, starving them and making immunotherapy treatments more effective. Although it’s still being studied in labs and not ready for patients, it shows promise for improving cancer treatments.
Additionally, The rising prevalence of medical conditions such as cancer, HIV/AIDS, and digestive disorders has led to an increased demand for glutamine. Patients with these conditions often have elevated requirements for glutamine to support their treatment and manage associated symptoms. Pharmaceutical formulations and supplements containing glutamine have become essential components of their therapeutic regimens.
Furthermore, ongoing research into the therapeutic potential of glutamine continues to drive innovation in product development and treatment protocols. As scientists uncover its physiological functions and benefits, new applications and formulations are being explored, further expanding the glutamine market. The outlook for the glutamine market remains promising, with continued growth anticipated as its importance in healthcare and medical treatment becomes increasingly recognized and validated.
Recent Developments
- In September 2020, Evonik, a German firm dealing with glutamic acid, and Unilever, a British corporation making consumer goods, partnered strategically. Evonik’s biotech know-how would serve as a critical tenet for Unilever’s Clean Future program through this partnership.
- In 2020, Kyowa Kirin and Ajinomoto worked together to study fermented glutamine for sports nutrition products. They wanted to see if it could make athletes perform better.
Glutamine Market Companies
- Kyowa Hakko Kirin Co., Ltd.
- Ajinomoto Co., Inc.
- Evonik Industries AG
- Metabolic Technologies, Inc.
- Fufeng Group
- Nutritech
- Battery Nutrition Limited
- Allmax Nutrition INC.
- Nutri Advanced Ltd
- Optimum Nutrition
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/glutamine-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5119
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare